Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 13797
Country/Region: South Africa
Year: 2017
Main Partner: Health Systems Trust
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $0 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Laboratory Infrastructure (HLAB) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: Adult Treatment (HTXS) $0
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
TB_PREV By Age/Sex (Numerator): <15, Female 2018 35
TB_PREV By Age/Sex (Numerator): <15, Male 2018 64
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 475
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 288
TB_PREV By Therapy type (Numerator): 6-12 Month IPT 2018 848
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 848
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 1,697
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 70
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 48
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 947
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 632
TB_PREV_den By Therapy type (Denominator): 6-12 Month IPT 2018 1,697